Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ik-Kyung Jang, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Ik-Kyung Jang and Robert Yeh.
Connection Strength

2.831
  1. Yeh RW, Baron SJ, Healy JL, Pomerantsev E, McNulty IA, Cruz-Gonzalez I, Jang IK. Anticoagulation with the direct thrombin inhibitor argatroban in patients presenting with acute coronary syndromes. Catheter Cardiovasc Interv. 2009 Aug 01; 74(2):359-64.
    View in: PubMed
    Score: 0.459
  2. Yeh RW, Everett BM, Foo SY, Dorer DJ, Laposata M, Van Cott EM, Jang IK. Predictors for the development of elevated anti-heparin/platelet factor 4 antibody titers in patients undergoing cardiac catheterization. Am J Cardiol. 2006 Aug 01; 98(3):419-21.
    View in: PubMed
    Score: 0.369
  3. Yeh RW, Jang IK. Argatroban: update. Am Heart J. 2006 Jun; 151(6):1131-8.
    View in: PubMed
    Score: 0.368
  4. Yonetsu T, Kato K, Uemura S, Kim BK, Jang Y, Kang SJ, Park SJ, Lee S, Kim SJ, Jia H, Vergallo R, Abtahian F, Tian J, Hu S, Yeh RW, Sakhuja R, McNulty I, Lee H, Zhang S, Yu B, Kakuta T, Jang IK. Features of coronary plaque in patients with metabolic syndrome and diabetes mellitus assessed by 3-vessel optical coherence tomography. Circ Cardiovasc Imaging. 2013 Sep; 6(5):665-73.
    View in: PubMed
    Score: 0.152
  5. Kato K, Yonetsu T, Kim SJ, Xing L, Lee H, McNulty I, Yeh RW, Sakhuja R, Zhang S, Uemura S, Yu B, Mizuno K, Jang IK. Comparison of nonculprit coronary plaque characteristics between patients with and without diabetes: a 3-vessel optical coherence tomography study. JACC Cardiovasc Interv. 2012 Nov; 5(11):1150-8.
    View in: PubMed
    Score: 0.144
  6. Yonetsu T, Kim JS, Kato K, Kim SJ, Xing L, Yeh RW, Sakhuja R, McNulty I, Lee H, Zhang S, Uemura S, Yu B, Kakuta T, Jang IK. Comparison of incidence and time course of neoatherosclerosis between bare metal stents and drug-eluting stents using optical coherence tomography. Am J Cardiol. 2012 Oct 01; 110(7):933-9.
    View in: PubMed
    Score: 0.140
  7. Armstrong EJ, Xing L, Zhang J, Zheng Y, Shunk KA, Yeh RW, Farzaneh-Far R, Yu B, Jang IK. Association between leukocyte telomere length and drug-eluting stent strut coverage by optical coherence tomography. J Am Coll Cardiol. 2012 Jun 12; 59(24):2218-9.
    View in: PubMed
    Score: 0.140
  8. Kato K, Yonetsu T, Kim SJ, Xing L, Lee H, McNulty I, Yeh RW, Sakhuja R, Zhang S, Uemura S, Yu B, Mizuno K, Jang IK. Nonculprit plaques in patients with acute coronary syndromes have more vulnerable features compared with those with non-acute coronary syndromes: a 3-vessel optical coherence tomography study. Circ Cardiovasc Imaging. 2012 Jul; 5(4):433-40.
    View in: PubMed
    Score: 0.140
  9. Yoon JH, Yeh RW, Nam KH, Hoffman WD, Agnihotri AK, Jang IK. Safety and efficacy of the argatroban therapy during the early post-cardiac surgery period. J Thromb Thrombolysis. 2010 Oct; 30(3):276-80.
    View in: PubMed
    Score: 0.124
  10. Baron SJ, Yeh RW, Cruz-Gonzalez I, Healy JL, Pomerantsev E, Garasic J, Drachman D, Rosenfield K, Jang IK. Efficacy and safety of argatroban in patients with heparin induced thrombocytopenia undergoing endovascular intervention for peripheral arterial disease. Catheter Cardiovasc Interv. 2008 Jul 01; 72(1):116-20.
    View in: PubMed
    Score: 0.106
  11. Cruz-Gonzalez I, Sanchez-Ledesma M, Osakabe M, Watanabe H, Baron SJ, Healy JL, Yeh RW, Jang IK. What is the optimal anticoagulation level with argatroban during percutaneous coronary intervention? Blood Coagul Fibrinolysis. 2008 Jul; 19(5):401-4.
    View in: PubMed
    Score: 0.106
  12. Yeh RW, Wiviott SD, Giugliano RP, Morrow DA, Shui A, Qin J, Scirica B, Bradner JE, Jang IK, Gibson CM, Antman EM. Effect of thrombocytopenia on outcomes following treatment with either enoxaparin or unfractionated heparin in patients presenting with acute coronary syndromes. Am J Cardiol. 2007 Dec 15; 100(12):1734-8.
    View in: PubMed
    Score: 0.102
  13. Cruz-Gonzalez I, Sanchez-Ledesma M, Baron SJ, Healy JL, Watanabe H, Osakabe M, Yeh RW, Jang IK. Efficacy and safety of argatroban with or without glycoprotein IIb/IIIa inhibitor in patients with heparin induced thrombocytopenia undergoing percutaneous coronary intervention for acute coronary syndrome. J Thromb Thrombolysis. 2008 Apr; 25(2):214-8.
    View in: PubMed
    Score: 0.100
  14. Ferencik M, Gregory SA, Butler J, Achenbach S, Yeh RW, Hoffmann U, Inglessis I, Cury RC, Nieman K, McNulty IA, Healy JA, Brady TJ, Semigran MJ, Jang IK. Analysis of cardiac dimensions, mass and function in heart transplant recipients using 64-slice multi-detector computed tomography. J Heart Lung Transplant. 2007 May; 26(5):478-84.
    View in: PubMed
    Score: 0.097
  15. Everett BM, Yeh R, Foo SY, Criss D, Van Cott EM, Laposata M, Avery EG, Hoffman WD, Walker J, Torchiana D, Jang IK. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery. Ann Thorac Surg. 2007 Feb; 83(2):592-7.
    View in: PubMed
    Score: 0.097
  16. Gregory SA, Ferencik M, Achenbach S, Yeh RW, Hoffmann U, Inglessis I, Cury RC, Nieman K, McNulty IA, Laffan JA, Pomerantsev EV, Brady TJ, Semigran MJ, Jang IK. Comparison of sixty-four-slice multidetector computed tomographic coronary angiography to coronary angiography with intravascular ultrasound for the detection of transplant vasculopathy. Am J Cardiol. 2006 Oct 01; 98(7):877-84.
    View in: PubMed
    Score: 0.093
  17. Foo SY, Everett BM, Yeh RW, Criss D, Laposata M, Van Cott EM, Jang IK. Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization. Am Heart J. 2006 Aug; 152(2):290.e1-7.
    View in: PubMed
    Score: 0.093
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.